NEWRON PHARMACEUT. EO-,20/ IT0004147952 /
03/05/2024 20:55:17 | Var. +0.8700 | Volume | Denaro21:31:16 | Lettera21:31:16 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
9.6200EUR | +9.94% | 350 Fatturato: 3,367 |
-Quantità in denaro: - | -Quantità in lettera: - | 166.66 mill.EUR | - | - |
GlobeNewswire
04:03
Mystik Dan Wins the Historic 150th Running of the Kentucky Derby Presented by Woodford Reserve
GlobeNewswire
03:43
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Equinix, Inc. with Losses to C...
GlobeNewswire
03:25
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cryoport, Inc....
GlobeNewswire
03:14
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sprout Social,...
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Spa...
GlobeNewswire
04/05
IRSA: China and France aspire to provide a positive example for peaceful interactions between tradit...
GlobeNewswire
04/05
IRSA: Chinese President Xi Jinping’ s visit to France opens a new chapter in China-EU relations
GlobeNewswire
04/05
IRSA: France and China embrace new chances for cultural interchange, as well as economic and commerc...